Klinger H P, Glasser M, Kava H W
Obstet Gynecol. 1976 Jul;48(1):40-8.
The chromosomes of 3080 products of conception, consisting primarily of newborn infants and medically induced abortions, were examined. These were from 3 major groups of women, those who had used oral contraceptives (primarily the combination types), those who had used nonhormonal contraceptives, and a control group of those who had not used any contraceptives. In the newborn study population, the chromosome abnormality rate was 5.4 per 1000 infants (when cases of proven hereditary involvement are excluded the figure drops to 3.6 per 1000), and in the entire induced-abortion study series it was 7.3 per 1000. These rates are very similar to those obtained in other surveys. The rate of chromosomally abnormal conceptuses increases with increasing maternal age in both the newborn and induced-abortion groups. No statistically significant relationships were found between the observed or age-adjusted rates of chromosome abnormalities and contraceptive history (P greater than .10 in all cases). The findings make it clear that the use of oral contraceptives has no large effect on the risk of having a chromosomally abnormal child although the possibility of a small increase or decrease in this risk, of at most about 10 per 1000, cannot be ruled out because of the small number of abnormalities found.
对主要由新生儿和人工流产产物组成的3080个妊娠产物的染色体进行了检查。这些产物来自三大类女性,即使用口服避孕药的女性(主要是复方类型)、使用非激素避孕药的女性以及未使用任何避孕药的对照组女性。在新生儿研究人群中,染色体异常率为每1000名婴儿中有5.4例(排除已证实有遗传因素的病例后,该数字降至每1000名中有3.6例),而在整个人工流产研究系列中,该比率为每1000名中有7.3例。这些比率与其他调查得出的比率非常相似。在新生儿和人工流产组中,染色体异常的妊娠产物比率均随母亲年龄的增加而升高。在观察到的或经年龄调整的染色体异常率与避孕史之间未发现统计学上的显著关系(所有情况下P均大于0.10)。研究结果清楚地表明,使用口服避孕药对生出染色体异常孩子的风险没有很大影响,不过由于发现的异常数量较少,不能排除这种风险最多增加或降低约千分之十的可能性。